News + Filings Holdings
|
Soleus Capital Management, L.P.
> YMAB
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Y-mAbs Therapeutics, Inc. | YMAB | 157,182 | 70,000 | 1,067,266,000 | 630,484,000 | $6,790.00 |
03/31/2023 | Y-mAbs Therapeutics, Inc. | YMAB | 87,182 | 0 | 436,782,000 | 11,334,000 | $5,010.00 |
12/31/2022 | Y-mAbs Therapeutics, Inc. | YMAB | 87,182 | 0 | 425,448,000 | 424,191,000 | $4,880.00 |
09/30/2022 | Y-mAbs Therapeutics, Inc. | YMAB | 87,182 | -49,000 | 1,257,000 | -803,000 | $14.42 |
06/30/2022 | Y-mAbs Therapeutics, Inc. | YMAB | 136,182 | -102,800 | 2,060,000 | -779,000 | $15.13 |
03/31/2022 | Y-mAbs Therapeutics, Inc. | YMAB | 238,982 | -71,512 | 2,839,000 | -2,194,000 | $11.88 |
12/31/2021 | Y-mAbs Therapeutics, Inc. | YMAB | 310,494 | 44,794 | 5,033,000 | -2,550,000 | $16.21 |
09/30/2021 | Y-mAbs Therapeutics, Inc. | YMAB | 265,700 | 121,400 | 7,583,000 | 2,706,000 | $28.54 |
06/30/2021 | Y-mAbs Therapeutics, Inc. | YMAB | 144,300 | 144,300 | 4,877,000 | 4,877,000 | $33.80 |
<< Prev Next >> |
|